Baolingbao Biology Co Ltd (002286) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Based on the latest financial reports, Baolingbao Biology Co Ltd (002286) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥134.96 Million ≈ $19.75 Million USD) by net assets (CN¥2.20 Billion ≈ $322.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Baolingbao Biology Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Baolingbao Biology Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Baolingbao Biology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Baolingbao Biology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Baolingbao Biology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hefei Lifeon Pharmaceutical Co Ltd SHE:003020	0.336x
OPTHEA LTD (SP.ADR/8) F:UKJ2	N/A
Greenlight Capital Re Ltd NASDAQ:GLRE	0.050x
Sichuan Etrol Technologies Co Ltd SHE:300370	0.014x
Yanpai Filtration Technology Co.Ltd. SHE:301081	N/A
PDS Limited NSE:PDSL	-0.080x
Zhejiang Tengen Electrics Co Ltd SHG:605066	N/A
Yantai Longyuan Power Tech SHE:300105	0.090x

Annual Cash Flow Conversion Efficiency for Baolingbao Biology Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Baolingbao Biology Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 002286 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.04 Billion ≈ $298.74 Million	CN¥248.72 Million ≈ $36.40 Million	0.122x	-14.39%
2023-12-31	CN¥1.98 Billion ≈ $290.25 Million	CN¥282.28 Million ≈ $41.31 Million	0.142x	+825.49%
2022-12-31	CN¥2.00 Billion ≈ $293.30 Million	CN¥30.82 Million ≈ $4.51 Million	0.015x	-86.48%
2021-12-31	CN¥1.81 Billion ≈ $265.33 Million	CN¥206.27 Million ≈ $30.18 Million	0.114x	-54.34%
2020-12-31	CN¥1.60 Billion ≈ $234.04 Million	CN¥398.46 Million ≈ $58.31 Million	0.249x	+153.58%
2019-12-31	CN¥1.57 Billion ≈ $229.30 Million	CN¥153.95 Million ≈ $22.53 Million	0.098x	+13.86%
2018-12-31	CN¥1.54 Billion ≈ $225.64 Million	CN¥133.05 Million ≈ $19.47 Million	0.086x	+456.56%
2017-12-31	CN¥1.53 Billion ≈ $223.17 Million	CN¥-36.91 Million ≈ $-5.40 Million	-0.024x	-133.49%
2016-12-31	CN¥1.51 Billion ≈ $220.69 Million	CN¥108.98 Million ≈ $15.95 Million	0.072x	+37.85%
2015-12-31	CN¥1.48 Billion ≈ $216.29 Million	CN¥77.49 Million ≈ $11.34 Million	0.052x	-25.34%
2014-12-31	CN¥1.45 Billion ≈ $212.09 Million	CN¥101.77 Million ≈ $14.89 Million	0.070x	+17.74%
2013-12-31	CN¥1.44 Billion ≈ $210.03 Million	CN¥85.60 Million ≈ $12.53 Million	0.060x	-48.22%
2012-12-31	CN¥817.45 Million ≈ $119.62 Million	CN¥94.15 Million ≈ $13.78 Million	0.115x	-48.98%
2011-12-31	CN¥760.53 Million ≈ $111.29 Million	CN¥171.70 Million ≈ $25.12 Million	0.226x	+478.31%
2010-12-31	CN¥703.11 Million ≈ $102.89 Million	CN¥27.45 Million ≈ $4.02 Million	0.039x	-41.88%
2009-12-31	CN¥662.61 Million ≈ $96.96 Million	CN¥44.51 Million ≈ $6.51 Million	0.067x	-85.56%
2008-12-31	CN¥238.05 Million ≈ $34.83 Million	CN¥110.77 Million ≈ $16.21 Million	0.465x	+13.88%
2007-12-31	CN¥193.28 Million ≈ $28.28 Million	CN¥78.98 Million ≈ $11.56 Million	0.409x	+140.46%
2006-12-31	CN¥112.53 Million ≈ $16.47 Million	CN¥19.12 Million ≈ $2.80 Million	0.170x	--

About Baolingbao Biology Co Ltd

SHE:002286 China Biotechnology

Market Cap

$512.90 Million

CN¥3.51 Billion CNY

Market Cap Rank

#12322 Global

#3630 in China

Share Price

CN¥9.21

Change (1 day)

-2.64%

52-Week Range

CN¥8.67 - CN¥12.87

All Time High

CN¥23.40